side effect that can be alarming to patients and can signal systemic reactions to the medications. The rashes associated with antipsychotic use are due to drug reactions and rashes due to injection sites. Rashes due to antipsychotic use that were reported in the literature are summarized in Table 1 . [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] In the psychiatric setting, rashes are most commonly associated with the mood stabilizer lamotrigine. However, it is important to realize the other skin manifestations after antipsychotic treatments. Discontinuation of the offending drug is important after identification of a drug reaction. Topical and oral medications can help alleviate the pruritus and erythema; however, no longterm consequences have been noted from the rashes associated with antipsychotic use.
We hope that by highlighting these dermatological side effects of antipsychotics will help with managing these occurrences in clinical practice.
Table 1. Reported rashes with antipsychotic treatments

Medication Route of administration Types of rash Location
Olanzapine Long acting injection 4 Unspecified Site of injection Oral 5 Pruritic, pigmented (allergic) Whole body, especially on her neck, neckline and shanks Oral 6 Pustules, erythema, pruritus Whole body, concentrated especially on her neck and face Oral 7 Erythematous Dependent areas of body (biopsy confirmed leukocytodastic vasculitis) Oral disintegrating tablet 8 Purpuric Generalized Clozapine Oral 9 Confluent, erythematous macules Trunk and lower extremities Oral 10 Erythematous macules Diffuse around neck and chest Oral 11 Itchy urticarial Hands and limbs and the back, particularly in the pressurized area Oral 12 Papular, pruritic, erythematous, Started on torso and spread to extremities and very well circumscribed Oral 13 Erythematopustular Unspecified Quetiapine Oral 14 Psoriatic Unspecified Aripiprazole Oral 15 Morbilliform maculopapular Anterior aspect of the chest and abdomen to the upper and lower limbs sparing the face and scalp and mucosal areas (buccal cavity)
